Genekam has developed
ultrasensitive Magnetic beads ELISA for SARS CoV-2
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
Genekam Biotechnology AG is taking part in exhibitions each year on a number of exhibitions as follows:
Here are some of photoes from 2013 from Düsseldorf, Germany: